Tumour-derived and host-derived nitric oxide differentially regulate breast carcinoma metastasis to the lungs

Carcinogenesis

Volumn 25, Issue 9, 2004, Pages 1559-1565

  Gauthier, Nolwenn ^a   Lohm, Sylvia ^b   Touzery, Claude ^c   Chantôme, Aurélie ^a   Perette, Bernard ^c   Reveneau, Sylvie ^a   Brunotte, François ^c   Juillerat Jeanneret, Lucienne ^b   Jeannin, Jean Francois ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^c CENTRE GEORGES FRANÇOIS LECLERC   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CARCINOGENICITY; CARCINOMA CELL; CELL ADHESION; CELL CLONE; CELL ISOLATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DEATH; ENDOTHELIUM CELL; HOST CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR CELL; WILD TYPE;

ANIMALS; CELL ADHESION; CELL DIVISION; CELL SURVIVAL; ENDOTHELIAL CELLS; ENZYME INHIBITORS; FEMALE; GUANIDINES; INDIUM RADIOISOTOPES; INTERLEUKIN-1; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 4544229787     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh158     Document Type: Article

References (40)

1. Khan,B.V., Harrison,D.G., Olbrych,M.T., Alexander,R.W. and Medford,R.M. (1996) Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc. Natl Acad. Sci. USA, 93, 9114-9119.
2. Spiecker,M., Darius,H., Kaboth,K., Hubner,F. and Liao,J.K. (1998) Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J. Leukoc. Biol., 63, 732-739.
3. Toyoshima,T., Kamijo,R., Takizawa,K., Sumitami,K., Hatori,M. and Nagumo,M. (1999) Nitric oxide up-regulates the expression of intercellular adhesion molecule-1 on cancer cells. Biochem. Biophys. Res. Commun., 257, 395-399.
4. Hirai,Y., Migita,K., Honda,S. et al. (2001) Effects of nitric oxide on matrix metalloproteinase-2 production by rheumatoid synovial cells. Life Sci., 68, 913-920.
5. Jadeski,L.C., Chakraborty,C. and Lala P.K. (2002) Role of nitric oxide in tumour progression with special reference to a murine breast cancer model. Can. J. Physiol. Pharmacol., 80, 125-135.
6. Millet,A., Bettaieb,A., Renaud,F. et al. (2002) Influence of the nitric oxide donor glyceryl trinitrate on apoptotic pathways in human colon cancer cells. Gastroenterology, 123, 235-246.
7. Lejeune,.P., Lagadec,P., Onier,N., Pinard,D., Ohshima,H. and Jeannin,J.F. (1994) Nitric oxide involvement in tumor-induced immunosuppression. J. Immunol., 152, 5077-5083.
8. Moochhala,S. and Rajnakova,A. (1999) Role of nitric oxide in cancer biology. Free Radic. Res., 6, 671-679.
9. Wink,D.A., Vodovotz,Y., Laval,J., Laval,F., Dewhirst,M.W. and Mitchell,J.B. (1998) The multifaceted roles of nitric oxide in cancer. Carcinogenesis, 19, 711-721.
10. Lee,Y.T. (1983) Breast carcinoma: pattern of metastasis at autopsy. J. Surg. Oncol., 23, 175-180.
11. Orr,F.W., Wang,H.H., Lafrenie,R.M., Scherbarth,S. and Nance,D.M. (2000) Interaction between cancer cells and the endothetium in metastasis. J. Pathol., 190, 310-329.
12. Zhang,H.J., Zhao,W., Venkataraman,S. et al. (2002) Activation of matrix metalloproteinase-2 by overexpression of manganese superoxide dismutase in human breast cancer MCF-7 cells involves reactive oxygen species. J. Biol. Chem., 277, 20919-20926.
13. Reveneau,S., Arnould,L., Jolimoy,G. et al. (1999) Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab. Invest., 79, 1215-1225.
14. Rockwell,S.C., Kallman,R.F. and Fajardo,L.F. (1972) Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J. Natl Cancer Inst., 49, 735-749.
15. Jeannin,J.F., Olsson,N.O. and Martin,F. (1983) Liposome induction or enhancement of macrophage-mediated cancer cell lysis. Int. J. Cancer, 31, 75-80.
16. Olsson,N.O., Leclerc,A., Jeannin,J.F. and Martin,F. (1982) A simple photometric microassay for the quantitative evaluation of macrophage-mediated cytotoxicity on adherent cancer cells. Ann. Immunol., 133D, 245-254.
17. Mosmann,T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods, 65, 55-63.
18. 15N]nitrate in biological fluids. Anal. Biochem., 126, 131-138.
19. Juillerat-Jeanneret,L., Aguzzi,A., Wiestler,O.D., Darekar,P. and Janzer,R.C. (1992) Dexamethasone selectively regulates the activity of enzymatic markers of cerebral endothelial cell lines. In Vitro Cell. Dev. Biol., 28A, 537-543.
20. Murata,J., Corradin,S.B., Janzer,R.C. and Juillerat-Jeanneret,L. (1994) Tumor cells suppress cytokine-induced nitric-oxide (NO) production in cerebral endothelial cells. Int. J. Cancer, 59, 699-705.
21. MacMicking,J.D., Nathan,C., Hom,G. et al. (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell, 81, 641-650.
22. Griffiths,M.J., Messent,M., MacAllister,R.J. and Evans,T.W. (1993) Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol., 110, 963-968.
23. Botti,C., Negri,D.R., Seregni,E. et al. (1997) Comparison of three different methods for radiolabelling human activated T lymphocytes. Eur. J. Nucl. Med., 24, 497-504.
24. Duenas-Gonzalez,A., Isales,C.M., del Mar Abad-Hernandez,M., Gonzalez-Sarmiento,R., Sangueza,O. and Rodriguez-Commes,J. (1997) Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease. Mod. Pathol., 10, 645-649.
25. Tschugguel,W., Schneeberger,C., Unfried,G. et al. (1999) Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade. Breast Cancer Res. Treat., 56, 145-151.
26. Vakkala,M., Kahlos,K., Lakari,E., Paakko,P., Kinnula,V. and Soini,Y. (2000) Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in situ and invasive breast carcinomas. Clin. Cancer Res., 6, 2408-2416.
27. Thomsen,L.L., Miles,D.W., Happerfield,L., Bobrow,L.G., Knowles,R.G. and Moncada,S. (1995) Nitric oxide synthase activity in human breast cancer. Br. J. Cancer, 72, 41-44.
28. Jadeski,L.C., Kathleen,O.H., Chakraborty,C. and Lala,P.K. (2000) Nitric oxide promotes murine mammary tumor growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int. J. Cancer, 86, 30-39.
29. Jadeski,L.C. and Lala,P.K. (1999). Nitric oxide synthase inhibition by NG-Nitro-L-Arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors. Am. J. Pathol., 155, 1381-1390.
30. Jadeski,L.C., Chakraborty,C. and Lala,P.K. (2003) Nitric oxide-mediated mammary tumor cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen activated protein kinase. Int. J. Cancer, 106, 496-504.
31. Shi,Q., Xiong,Q., Wang,B., Le,X., Khan,N.A. and Xie,K. (2000) Influence of nitric oxide synthase II gene disruption on tumor growth and metastasis. Cancer Res., 60, 2579-2583.
32. Wang,B., Xiong,Q., Shi,Q., Tan,D., Le,X. and Xie,K. (2001) Genetic disruption of host nitric oxide synthase II gene impairs melanoma-induced angiogenesis and suppresses pleural effusion. Int. J. Cancer, 91, 607-611.
33. Thomsen,L.L., Scott,J.M., Topley,P., Knowles,R.G., Keerie,A.J. and Frend,A.J. (1997) Selective inhibition of nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res., 57, 3300-3304.
34. Orucevic,A., Bechberger,J., Green,A.M., Shapiro,R.A., Billiar,T.R. and Lala,P.K. (1999) Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int. J. Cancer, 81, 889-896.
35. Lefer,D.J., Scalia,R., Campbell,B. et al. (1997) Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J. Clin. Invest., 99, 684-691.
36. Kubes,P., Suzuki,M. and Granger,D.N. (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl Acad. Sci. USA, 88, 4651-4655.
37. Liu,P., Yin,K., Nagele,R. and Wong,P.Y. (1998) Inhibition of NOS attenuates peroxynitrite generation, but augments neutrophil infiltration in hepatic ischemia-reperfusion. J. Pharmacol. Exp. Ther., 284, 1139-1146.
38. Liu,P., Xu,B., Hock,C.E., Nagele,R., Sun,F.F. and Wong,P.Y. (1998) NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R. Am. J. Physiol., 275, H2191-H2198.
39. Yudoh,K., Matsui,H. and Tsuji,H. (1997) Nitric oxide induced by tumor cells activates tumor cell adhesion to endothelial cells and permeability of the endothelium in vitro. Clin. Exp. Metastasis, 15, 557-567.
40. Gries,A., Bode,C., Peter,K. et al. (1998) Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo. Circulation, 97, 1481-1487.